Logo
  • Portfolio
  • People
  • Investors
  • News
  • Contact Us
  • Portfolio
  • People
  • Investors
  • News
  • Contact Us

Press Releases

Press Releases | 27/03/2024

Proposed voluntary cancellation of admission of Ordinary Shares to trading on AIM

Press Releases |

Half-year results for the six months ended 31 January 2024

Press Releases | 23/01/2024

Result of AGM

Press Releases | 18/01/2024

Board Change

Press Releases | 03/01/2024

AstraZeneca triggers $11 million preclinical milestone payment to C4X Discovery under its NRF2 exclusive worldwide licence agreement worth up to $402 million

Press Releases | 18/12/2023

Posting of 2023 Annual Report and Notice of AGM

Press Releases | 14/12/2023

Full Year Results 2023

Press Releases | 01/08/2023

Strategic Divestment of C4XD’s Orexin-1 Receptor Antagonist Programme to Indivior for £15.95 Million

Press Releases | 20/06/2023

Board Change

Press Releases | 01/06/2023

MALT-1 Inhibitor Programme Update

Posts navigation

Older posts
Newer posts

Categories

  • News
  • Press Releases
  • Scientific Papers

Archives

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020

Contact us

contact@c4xdiscovery.com

Copyright ©2026 C4XD Holdings Limited

privacy policy
  • Portfolio
  • People
  • Investors
  • News
  • Contact Us

C4X Discovery Holdings Ltd
1 Park Row
Leeds
LS1 5AB
United Kingdom

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}